Fundz

Jeito Capital Co-Leads $76 Million Series A Financing For Cdr-Life, Its 10Th Investment Since Its Launch

PRIVATEApr 13, 2022

Amount Raised

$76 Million

Round Type

Series A

BiotechnologyScience And Engineering

Description

Jeito Capital ("Jeito"), a leading independent Private Equity firm dedicated to biotech and biopharma, announced today that it has co-led a $76 million Series A financing round in CDR-Life, a privately-held biotech company developing a new generation of immuno-oncology therapies.

Quick answer

CDR-Life raised $76 Million in a Series A round, dated April 13, 2022.

How much did CDR-Life raise?
CDR-Life raised $76 Million in a Series A round on April 13, 2022.
What does CDR-Life do?
CDR-Life develops highly targeted T cell engagers (TCEs) for the treatment of solid cancers and autoimmune diseases.
Who are the decision-makers at CDR-Life?
Fundz holds 1 contact at CDR-Life. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as CDR-Life that raised within 45 days of this round, from Fundz verified event records.

  • Full Life Technologies raised $37M (Series A) on May 26, 2022.
  • Terremoto Biosciences raised $75M (Series A) on May 25, 2022.
  • 22nd Century raised $58M on May 25, 2022.
  • OliX Pharmaceuticals raised $45M (Funding Round) on May 25, 2022.
  • Vyriad raised $30M (Series B) on May 17, 2022.
  • Classiq raised an undisclosed amount (Funding Round) on May 16, 2022.

Who to call at CDR-Life, and when

A new round usually means CDR-Life is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CDR-Life raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CDR-Life, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CDR-Life. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CDR-Life

About

CDR-Life develops highly targeted T cell engagers (TCEs) for the treatment of solid cancers and autoimmune diseases. Our M-gager® platform delivers TCEs against challenging but cancer-specific intracellular and surface antigens through unparalleled target-specificity. With our first oncology program now in clinical trials, we are advancing a pipeline of potent and selective TCE therapeutics. Our partnership with Boehringer Ingelheim on a molecule derived from our M-gager® platform, progressing to Phase 2 trials, demonstrates the potential of our antibody-derived molecules. Backed by leading cross-Atlantic investors, our team is committed to bringing life-changing, disease-modifying medicines to patients globally.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CDR-Life raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for CDR-Life's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

CDR-Life raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.